Results 211 to 220 of about 10,318 (317)

Rethinking control‐IQ+ technology: Simple strategies for easy optimization

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3502-3514, May 2026.
Abstract Control‐IQ+ is an automated insulin delivery (AID) algorithm approved for people with type 1 diabetes aged 2+ years and adults aged 18+ years with type 2 diabetes. While numerous publications support improved glycaemia and quality of life for people with diabetes, this practice paper is intended to encourage uptake for healthcare professionals
Viral N. Shah, Pratik Choudhary, Ilana Halperin, Ivana Rabbone, Dessi P. Zaharieva, Laurel Messer   +5 more
wiley   +1 more source

Real‐world treatment trajectories preceding GLP‐1 receptor agonist initiation in type 2 diabetes: A descriptive UK population‐based cohort study on adherence to national clinical guidelines

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3692-3702, May 2026.
Abstract Aims To investigate glucose‐lowering treatment trajectories preceding glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) initiation in UK primary care, while assessing alignment with contemporary UK clinical guidelines, considering calendar time, cardiovascular disease (CVD) history, and obesity status.
Franziska S. Ulrich, Morten Frost Nielsen, Nicola Napoli, Andrea M. Burden   +3 more
wiley   +1 more source

Evaluating Suicidal Risk in GLP-1RA Therapy: An Umbrella Review of Meta-Analytic Evidence. [PDF]

Healthcare (Basel)
Ștefănescu C, Bratu EA, Pelin AM, Boroi D, Crecan-Suciu BD, Ștefănescu V.   +5 more
europepmc   +1 more source

GLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1 Pathway

, 2023
Jie Xiang, Liyan Qin, Jinling Zhong, Xia Ning, Yuzhen Liang   +4 more
openalex   +2 more sources

SGLT2 inhibitors, but not GLP-1 receptor agonists, reduce incidence of gout in people living with type 2 diabetes across the therapeutic spectrum

Purpose: This study aimed to evaluate the relative association between sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1Ra) with the incidence of gout in patients with type 2 diabetes (T2D) using real-
Alam, Uazman, Anson , Matthew, Cuthbertson, Daniel J., Henney, Alexander, Ibarburu, Gema H., Lip , Gregory Y.H, Preston, Frank G, Riley, David R, Zhao, Sizheng   +8 more
core   +3 more sources

Improving nutritional assessment in GLP-1RA therapy: Beyond self-reports to equitable interventions. [PDF]

Obes Pillars
Aphale P, Shekhar H, Dokania S.
europepmc   +1 more source

SAT-416 The impact of SGLT-2i and GLP-1RA on liver-related events in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and network meta-analysis

Lu Li, Ka Shing Cheung, Xianhua Mao, Lung‐Yi Mak, Rex Wan‐Hin Hui, Man‐Fung Yuen, Wai‐Kay Seto   +6 more
openalex   +1 more source

Effectiveness of GLP-1RA according to different type 2 diabetes phenotypes: A retrospective study. [PDF]

Diabetes Obes Metab
Caruso I, Giordano F, Matichecchia II, Di Gioia L, Di Molfetta S, Cignarelli A, Sorice GP, Natalicchio A, Laviola L, Giorgino F.   +9 more
europepmc   +1 more source

New Opportunities Beyond Intensive Insulin Therapy for Improving Vascular Health of People Living With Type 1 Diabetes

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
Djordje S. Popovic, Zoltan Kender, Theocharis Koufakis   +2 more
wiley   +1 more source

Comparison of SGLT2 Inhibitors for New‐Onset Proteinuria Risk in Patients With Type 2 Diabetes and Preserved Kidney Function

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 4314-4325, May 2026.
ABSTRACT Aims To compare the effects of individual SGLT2 inhibitors on preventing new‐onset proteinuria in patients with type 2 diabetes and preserved kidney function. Materials and Methods A target trial emulation was performed using commercially available databases, including health checkups and claims data, between April 1, 2014 and March 31, 2023 ...
Hiroki Nobayashi, Michihiro Satoh, Takuo Hirose, Shingo Nakayama, Yutaro Iwabe, Hideaki Hashimoto, Takahisa Murakami, Kouji Okada, Takefumi Mori, Hirohito Metoki   +9 more
wiley   +1 more source